Wegener’s granulomatosis: Clinical aspects

Gary S. Hoffman, Wolfgang L. Gross


Wegener’s granulomatosis (WG) affects at least I in 30,000 people in the United States (I). A retrospective review of hospitalizations in a Norwegian community suggested that prevalence in that country may be as great as I in 20,000 (2). The great majority of patients are adults, although individuals of all age groups can be affected. Most large studies do not reveal significant gender differences (3-5). Although WG is recognized predominantly in Caucasians, it also occurs in persons of all other ethnic and racial backgrounds. African-American patients are relatively underrepresented, comprising less than 8% of patients in the United States, while contributing II % of the general population.

Original languageEnglish
Title of host publicationInflammatory Diseases of Blood Vessels
Number of pages17
PublisherCRC Press
Publication date01.01.2000
ISBN (Print)9780824703844
ISBN (Electronic)9780824746599
Publication statusPublished - 01.01.2000

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Wegener’s granulomatosis: Clinical aspects'. Together they form a unique fingerprint.

Cite this